1. Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19. Issue 6 (June 2022) Authors: Ader, Florence; Bouscambert-Duchamp, Maude; Hites, Maya; Peiffer-Smadja, Nathan; Mentré, France; Burdet, Charles; Aboab, Jérôme; Ader, Florence; Ait-Oufella, Hafid; Altdorfer, Antoine; Andrejak, Claire; Andreu, Pascal; Argaud, Laurent; Bani-Sadr, Firouzé; Belhadi, Drifa; Belkhir, Leila; Benezit, ... Journal: Lancet infectious diseases Issue: Volume 22:Issue 6(2022) Page Start: 764 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial. Issue 2 (February 2022) Authors: Ader, Florence; Bouscambert-Duchamp, Maude; Hites, Maya; Peiffer-Smadja, Nathan; Poissy, Julien; Belhadi, Drifa; Diallo, Alpha; Lê, Minh-Patrick; Peytavin, Gilles; Staub, Thérèse; Greil, Richard; Guedj, Jérémie; Paiva, Jose-Artur; Costagliola, Dominique; Yazdanpanah, Yazdan; Burdet, Charles; Ment... Journal: Lancet infectious diseases Issue: Volume 22:Issue 2(2022) Page Start: 209 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗